Escitalopram is a generic prescription drug used to treat depression and anxiety. Escitalopram comes in oral forms, including an oral tablet. Specifically, doctors prescribe escitalopram to treat: ...

August 10, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for dantrolene sodium injectable 20 mg/vial for the management of malignant hyperthermia; ...

March 23, 2009 — Escitalopram oxalate (Lexapro, Forest Laboratories, Inc) has been approved by the US Food and Drug Administration (FDA) for the acute and maintenance treatment of major depressive ...

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. This page contains answers to some common questions about Lexapro. It does not contain all the information ...

NEW YORK, December 10 – Forest Laboratories, Inc. (NYSE: FRX) announced today the results of a clinical study, which showed that Lexapro TM (escitalopram oxalate) is as effective and well tolerated as ...

NEW YORK, December 18 - Forest Laboratories, Inc. (NYSE:FRX) announced today that the U.S. Food and Drug Administration (FDA) has approved Lexapro (escitalopram oxalate), a selective serotonin ...

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has commenced commercial launch of Escitalopram Oxalate Tablets, the Company's generic version of ...

Escitalopram is indicated for the treatment of major depressive disorder. This tentative approval is for the generic bioequivalent product to Lexapro (R), which is offered by Forest Laboratories, Inc.

NEW YORK, Sept. 5 -- Forest Laboratories and H. Lundbeck A/S of Denmark said today that the U.S. Court of Appeals for the Federal Circuit has affirmed a July 13, 2006 decision by the U.S. District ...

MUMBAI, India Indian drug manufacturer Lupin announced Monday that the Food and Drug Administration had approved its generic anti-depressant escitalopram oxalate tablets. New York-based Forest ...